Group items tagged

The Welsh government has reached an agreement with the NHS and Community Pharmacy Wales (CPW)-the statutory representative body for all community pharmacies-on a six per cent funding increase as part of the 2024/25 Community Pharmacy Contractual Framework (CPCF). The £9.9 million increase will bring the total CPCF funding to £175 million per year, representing a 24 per cent rise in funding since 2017. In a statement published on 20 December 2024, Jeremy Miles, cabinet secretary for health and social care, said that the additional investment will be used to address "both immediate pressures facing community pharmacies and to maintain momentum on our longer-term ambitions for reform." Miles also said that the government would continue to invest in integrating pharmacies in primary care clusters, developing the skills and scope of practice of the wider community pharmacy workforce including pharmacy technicians, and the Choose Pharmacy IT system. In contrast, community pharmacies in England are still awaiting progress on CPCF negotiations for 2024/25. Last month, Community Pharmacy England (CPE) warned of the sector's worsening financial situation, urging ministers to provide immediate funding relief.

"I dread the day, the accountant turns to me and says 'this isn't working' - as an owner, we shelter our patients and teams from the financial pressures we feel on a daily basis," shares S.G Barai Pharmacy owner, Reena Barai. Today, S.G Barai Pharmacy in Sutton, Surrey joined pharmacies nationwide in the #SaveOurPharmacies day of action, organised by the National Pharmacy Association (NPA) to spotlight the critical funding crisis facing community pharmacies across the UK. Recent figures reveal that over the past decade, more than 1,400 pharmacies have closed in England, Wales, and Northern Ireland, with additional closures looming in Scotland due to financial pressures. The NPA reports that three-quarters of pharmacies are operating at a loss, exacerbated by real-terms cuts to funding. "We turned our lights off and wore black today to symbolize the precarious situation pharmacies like ours are facing," said Reena Barai who owns the pharmacy.

Community pharmacies are bracing themselves to withdraw services from patients after an industry ballot supported plans for major action unless the government provided a significant increase in funding for the sector. The National Pharmacy Association (NPA) on Tuesday (12) announced the results of an unprecedented collective action ballot in which nearly all pharmacy owners, who participated in the ballot, voted to limit their services, insisting that a lack of additional funding is jeopardising patients health and safety. Over 63 per cent of NPA members in England, Wales and Northern Ireland took part in the ballot- representing 3,049 independent community pharmacies in England alone, or 3,399 with Wales and Northern Ireland included. Nearly 98 per cent of pharmacy owners in England voted to reduce their opening hours to the minimum required by their contract. This could result in fewer pharmacies remaining open during evenings and weekends. More than 93 per cent voted to stop offering "unfunded" free home deliveries of medicines, and over 96 per cent voted to withdraw from locally commissioned services, including certain addiction support, emergency contraception, and stop smoking services.

Knights Pharmacy has significantly expanded its footprint in South Wales through its recent acquisition of pharmacies in Abercarn and Cwmcarn from the Evans Group. This move marks another strategic expansion for the Redditch-based pharmacy group, bolstered by funding from HSBC UK. The Abercarn site, which handles approximately 12,000 medication items annually, and the Cwmcarn site, dispensing around 5,000 items, will now operate under the Knights Pharmacy banner. This acquisition adds to Knights Pharmacy's growing portfolio, which now spans 49 community sites across England and Wales, a substantial increase from 18 sites just three years ago.

The Pharmacists' Defence Association (PDA) has reacted to the chief pharmaceutical officer (CPhO) for Wales's offer for community pharmacy contractors, offering a funding uplift for community pharmacy on the condition of an increase in pay for some staff by at least the amount currently being imposed upon NHS employees. The PDA has expressed a mixed reaction to the intervention being attempted by the Welsh government. "It is unusual for a government to be so closely involved in the pay of their suppliers' employees and those at some community pharmacy employers have a contractual right to a pay review at times of year that may not synchronize with the government's financial cycle, so this initiative may have different impacts at different employers," said the association. "In addition, the PDA negotiates pay at the largest two community pharmacy employers and works alongside other trade unions that organise other pharmacy workers. This government intervention must not disrupt or attempt to bypass those processes."

Recently, the English Health Secretary has talked about introducing a 'Pharmacy First' model similar to that which exists in Scotland. This would be a win-win outcome providing people with better access to essential healthcare support, advice and treatment whilst relieving strain on other parts of the NHS, not least GPs and A&E. It is a no-brainer and yet despite a few media headlines there are still no firm proposals on the table to make this a reality. It surely cannot be right that you can receive a broad range of patient care services in Scotland which are not available in England. It works well in Scotland, Wales is keen to develop more pharmacy-based services and Northern Ireland, leaving aside the current funding dispute, has had a minor ailments service for many years. If the English Health Secretary is sincere in his interest in adopting an English version of the Scottish model, then there are critical aspects he needs to consider. Firstly, start with the patient journey through the healthcare ecosystem from illness prevention through to long-term condition management. What is the role of community pharmacy and how do we guide people to seek support from the most appropriate healthcare professional? What is the vision for community pharmacy delivering patient care in the next decade? The lesson from Scotland is that the government needs to sit down with the sector and map that out together. There are no quick fix overnight solutions. This needs to be a long-term commitment backed by adequate funding. Supervision regulations need to change and there needs to be a thought through workforce strategy which avoids community pharmacy shortages as that does nothing to deliver improved patient outcomes.

The Pharmacists' Defence Association (PDA) on Wednesday confirmed that several MPs have come forward to support their campaign for fair funding for pharmacy students, as well as announced their plan to take the campaign to Wales. The campaign that began last year is focussed on the issue of pharmacy students being left out of the scope of the NHS Learning Support Fund (LSF), which provides supplementary funding for healthcare students in England. MPharm students and PDA Student Reps have been sending letters to their MPs requesting them to escalate the issue to the health minister, and they have been able to gather considerable support. "There appears to be some cross-party support for the campaign, with welcome responses coming from Labour, Liberal Democrat and Conservative MPs," the PDA said.

To support NHS, clear the backlog created by the Covid-19 pandemic and help community pharmacies support more people, the Welsh government has announced an allocation of further £12.5 million funding. Of the total amount, £10mn will be distributed across the 22 local authorities to buy equipment to help people to live independently in their own homes post hospital stay. The remainder, £2.5mn, will be used to support community pharmacists and patients to improve access to treatment and advice for a range of common ailments. The move is aimed at alleviating waiting times and reducing winter pressures on the NHS. Commenting on the announcement, Elen Jones, Royal Pharmaceutical Society director for Wales said: "We are delighted that the Welsh government continue to recognise the value of pharmacists in patient care and we welcome this additional investment and support for Community Pharmacy teams across Wales.

Trainee pharmacists at Boots in England and Northern Ireland will get a pay increase from 1st August. The new pay rates agreed between the Pharmacists' Defence Association (PDA) Union and Boots was announced on Tuesday (4 July). The joint statement released by Boots and PDA Union said: "Following discussions, we are pleased to announce that there will be a pay increase for Trainee Pharmacists, in England and Northern Ireland, commencing in role this summer." Trainee Pharmacists working in Boots Pharmacies in Wales are employed directly by the NHS and are therefore outside the scope of the pay negotiations between Boots and the PDA Union. Funding for each Boots Trainee Pharmacist in Scotland is at a higher level and Boots continues to pass on the fully funded amount as salary to those team members

As part of its centenary celebrations, the National Pharmacy Association (NPA) has raised more than eleven thousand pounds for mental health charity Mind. A total of £11,583 was raised for Mind and the Association continues to encourage members to support the charity. The NPA marked its 100th birthday in 2021 and partnered with Mind in England and Wales, and equivalent charities in Scotland and Northern Ireland - SAMH (Scottish Association for Mental Health) and Inspire Wellbeing - to raise awareness of pharmacy services for people with mental health problems and to generate funds for the work of these charities. The NPA held set-piece events, such as sponsored walks, and pharmacists, colleagues and their families and friends were encouraged to organise their own activities. Chief executive of the NPA, Mark Lyonette, said: "I was delighted to be at our sponsored walk in St Albans, home of our head office, last year. This and other fundraising events all underlined the message that community pharmacies are concerned with the wellbeing of the whole person - mind as well as body."

The Pharmacists' Defence Association (PDA) has raised concerns about inaccuracies in media reports regarding a campaign launched by the National Pharmacy Association (NPA) to ballot members in protest over funding issues. The PDA clarified that only trade unions, like the PDA Union, can conduct ballots for industrial action. Therefore, it argued that the NPA's action should not be "inaccurately described as a strike or industrial or collective action." The PDA further explained that NPA's proposed ballot pertains to a contractual dispute between businesses operating community pharmacies and the NHS commissioners in England, Wales, and Northern Ireland. Additionally, the PDA noted that the NPA is not conducting a ballot for its members in Scotland. While some reports have stated that 'pharmacists' are being balloted for the first time to take collective action, the PDA pointed out that many NPA members are, in fact, business owners and investors, not pharmacists.

Alliance Healthcare UK team members Nick Atkins, Swansea Service Centre Manager, and Karl Goodall, Swansea Driver Team Manager, have climbed Pen y Fan in South Wales to support the Alzheimer's Society and raise money for dementia. The pair raised over £1,500, a cause close to Nick's heart, as his mother is a dementia patient. Dementia mainly affects people aged 65 and over, with 65 per cent of the 944,000 individuals living with dementia in the UK being women. Nick and Karl, dressed as 'glamorous grannies' with wigs, tights, and dresses, completed the mountain trek in six hours, carrying an Alliance Healthcare medicines cool box weighing over 35 kg. Alzheimer's Society supports people with dementia and their carers through national care and research efforts. Alzheimer's Society Cymru is the sole UK dementia charity funding both biomedical and care research.

A new report has highlighted that the public places a higher value on medicines for severe medical conditions, such as terminal cancer, than the thresholds currently used by the National Institute for Health and Care Excellence (NICE). The study, conducted by the Office of Health Economics (OHE), found a misalignment between NICE's current 'severity modifier'-which determines whether a medicine is recommended for coverage on the National Health Service (NHS)-and the UK public's preference for prioritising health gains for more severe diseases. The research, commissioned and funded by the Association of the British Pharmaceutical Industry (ABPI), also indicated that the public is willing to pay more for medicines used to treat patients with severe disease. Titled 'Understanding Societal Preferences for Priority by Disease Severity in England and Wales,' the report suggested that NICE's current severity modifier may be limiting access to innovative treatments for NHS patients. The ABPI has called on the government and NICE to adopt a more flexible approach when assessing medicines for severe conditions.